Sol-Gel Technologies SLGL
NASDAQ SLGL
$69.96 -0.14 (-0.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

Sol-Gel Technologies (SLGL) Long-Term Investments (2016 - 2026)

Sol-Gel Technologies (SLGL) posted quarterly Long-Term Investments of $1.3 million for Q1 2026, up 2.71% year-over-year from $1.3 million in Q1 2025, and little changed quarter-over-quarter from $1.3 million in Q4 2025.

Analysis

Sol-Gel Technologies (SLGL) Long-Term Investments (2016 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has reported Long-Term Investments for 11 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Long-Term Investments rose 2.71% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (up 2.71% YoY), while the FY2025 annual figure was $1.3 million, up 2.56% from the prior year.
  • Long-Term Investments was little changed at $1.3 million in Q1 2026 per SLGL's latest filing, from $1.3 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $1.3 million in Q1 2026 and bottomed at $1.3 million in Q1 2024.
  • Historically, Long-Term Investments has averaged $1.3 million across 5 years, with a median of $1.3 million in 2024.
  • Annual changes were most pronounced in 2024 — Long-Term Investments slipped 2.47% — and 2025, when it climbed 2.75%.
  • Sol-Gel Technologies' Long-Term Investments stood at $1.3 million in 2022, then decreased by 0.31% to $1.3 million in 2023, then gained by 0.55% to $1.3 million in 2024, then climbed by 2.56% to $1.3 million in 2025, then grew by 0.3% to $1.3 million in 2026.
  • Business Quant data shows SLGL's Long-Term Investments at $1.3 million in Q1 2026, $1.3 million in Q4 2025, and $1.3 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 5.79 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 9.83 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -4.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 1.77 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 22.17 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 372.10 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Sol-Gel Technologies 194.01 Mn 146.08 Mn - 1.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.34 Mn
Mar 31, 2026 1.33 Mn
Dec 31, 2025 1.32 Mn
Sep 30, 2025 1.31 Mn
Jun 30, 2025 1.31 Mn
Mar 31, 2025 1.29 Mn
Dec 31, 2024 1.29 Mn
Sep 30, 2024 1.29 Mn
Jun 30, 2024 1.27 Mn
Mar 31, 2024 1.26 Mn
Dec 31, 2023 1.28 Mn
Sep 30, 2023 1.29 Mn
Jun 30, 2023 1.29 Mn
Mar 31, 2023 1.30 Mn
Dec 31, 2022 1.29 Mn
Sep 30, 2022 1.29 Mn
Jun 30, 2022 1.29 Mn
Mar 31, 2022 1.30 Mn
Dec 31, 2021 1.30 Mn
Sep 30, 2021 1.29 Mn